Kevin McCaffrey

Most Recent Articles by Kevin McCaffrey

Five things for pharma marketers to know: Tuesday, March 28, 2017

Five things for pharma marketers to know: Tuesday, March 28, 2017

By

Ovarian cancer drug nabs FDA approval; Senate committee to investigate opioid manufacturers; Allergan's acne drug reports positive Phase-III results

Veeva and QuintilesIMS tussle over customer reference data

Veeva and QuintilesIMS tussle over customer reference data

By

Veeva is countersuing QuintilesIMS in the wake of allegations that Veeva mishandled its proprietary data.

Five things for pharma marketers to know: Thursday, March 23, 2017

Five things for pharma marketers to know: Thursday, March 23, 2017

By

AHCA set for vote; J&J halts YouTube ads; approval decisions loom for Sanofi, Roche

Five things for pharma marketers to know: Tuesday, March 21, 2017

Five things for pharma marketers to know: Tuesday, March 21, 2017

By

Eli Lilly claims it only realizes small percentage of list price increases; PBMs become latest target in pricing backlash; AHCA revised

Low-T DTC ads linked with more testing — and more prescriptions

Low-T DTC ads linked with more testing — and more prescriptions

By

Researchers found that DTC advertising was associated with significant increases in testing and treatment for these drugs

More Articles by Kevin McCaffrey

OPINION

Gottlieb Likely to Take On Off-Label, Predictability at the FDA

Newsletters